Vanda and FDA's agreement includes expedited re-reviews of Tradipitant and Hetlioz applications, with target action dates in late 2025 and early 2026. The collaborative framework involves pausing ...

The cost and duration of clinical trials have escalated dramatically in the past 20 years, hampering introduction of new therapies and limiting people's access to high-quality clinical research.

The Japan Science and Technology Agency (JST) will support 2 jointly selected projects in the “Sustainable Urbanisation Global Initiative: Food-Water-Energy Nexus” Collaborative Research Action (CRA), ...